Want to see CH:BSLN full AI Analyst Report?
Basilea Pharmaceutica (BSLN) Q2 2025 Earnings Report
CH:BSLN Q2 2025 EPS Results
- Actual EPS
- CHF 1.26
- Consensus EPS
- CHF 2.03
- Beat/Miss
- Missed by -CHF 0.77
- One Year Ago EPS
- CHF 1.58
CH:BSLN Q2 2025 Revenue Results
- Actual Revenue
- CHF 103.96M
- Expected Revenue
- CHF 98.20M
- Beat/Miss
- Beat by +CHF 5.76M
- YoY Revenue Growth
- +36.26%
Earnings Announcement Details
- Quarter
- Q2 2025
- Date
- 08/19/2025
- Time
- Before Open
- Conference Call
- Tuesday, August 19, 2025
CH:BSLN Upcoming Earnings
Basilea Pharmaceutica's next earnings date is estimated for February 16, 2027, based on past reporting schedules.
Q2 2025 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:BSLN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 16, 2027 | 2026 (Q4) | 2.88- | 1.99 | ― | ― |
| Aug 18, 2026 | 2026 (Q2) | 3.342.13 | 1.26 | 69.05% (+0.87) | |
| Feb 17, 2026 | 2025 (Q4) | 1.641.99 | 4.7 | -57.70% (-2.71) | |
| Aug 19, 2025 | 2025 (Q2) | 2.031.26 | 1.57 | -20.00% (-0.32) | |
| Feb 18, 2025 | 2024 (Q4) | 3.244.70 | -1.71 | 375.66% (+6.41) | |
| Aug 13, 2024 | 2024 (Q2) | 1.171.57 | 2.43 | -35.21% (-0.86) | |
| Feb 13, 2024 | 2023 (Q4) | -2.02-1.71 | 2.05 | -183.17% (-3.75) | |
| Aug 15, 2023 | 2023 (Q2) | 0.812.43 | -1.03 | 336.02% (+3.46) | |
| Feb 14, 2023 | 2022 (Q4) | -1.302.05 | 1.26 | 62.70% (+0.79) | |
| Aug 16, 2022 | 2022 (Q2) | -1.28-1.03 | -1.84 | 44.02% (+0.81) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
